If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Rule 8.3- African Platinum

21 Feb 2007 15:13

UBS AG21 February 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATIONName of person dealing (Note 1) UBS AG London Branch Company dealt in African Platinum PlcClass of relevant security to which the dealings Ord 0.1pbeing disclosed relate (Note 2)Date of dealing 20 February 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 18,896,807 3.97% 0 0.00%(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 18,896,807 3.97% 0 0.00% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) PURCHASE 32,600 54.5p PURCHASE 967,400 54.5 PURCHASE 176,496 54.5 PURCHASE 50,000 54.5 PURCHASE 250,000 54.5 PURCHASE 500,000 54.5 (b) Derivatives transactions (other than options) Product name, Long/short (Note Number of securities Price per unit e.g. CFD 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/ call purchasing, to which European received option varying etc. the option etc. per unit relates (Note 5) (Note 7) (ii) ExercisingProduct name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 21 February 2007 Contact name JOSEPH EVANS Telephone number 020 7567 8286 If a connected EFM, name of offeree/offeror with N/Awhich connectedIf a connected EFM, state nature of connection N/A(Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Dec 20228:58 amRNSForm 8.5 (EPT/RI)
12th Dec 20228:26 amRNSForm 8.3 - Appreciate Group PLC
9th Dec 20223:03 pmRNSForm 8.3 - APPRECIATE GROUP PLC
9th Dec 20228:57 amRNSForm 8.5 (EPT/RI)
9th Dec 20228:22 amRNSForm 8.3 - Appreciate Group PLC
8th Dec 20221:57 pmRNSHolding(s) in Company
6th Dec 20224:59 pmRNSHolding(s) in Company
6th Dec 20223:05 pmRNSForm 8.3 - APPRECIATE GROUP PLC
6th Dec 20222:26 pmRNSForm 8.3 - Appreciate Group plc
6th Dec 20229:20 amRNSForm 8.5 (EPT/RI)
5th Dec 20223:09 pmRNSForm 8.3 - Appreciate Group PLC
5th Dec 20221:28 pmRNSHolding(s) in Company
5th Dec 202210:31 amRNSForm 8.3 - Appreciate Group plc
5th Dec 20228:50 amRNSForm 8.5 (EPT/RI)
2nd Dec 20227:00 amRNSPublication of Scheme Document
1st Dec 20223:03 pmRNSForm 8.3 - APPRECIATE GROUP PLC
1st Dec 20229:02 amRNSForm 8.5 (EPT/RI)
29th Nov 202210:22 amRNSForm 8.5 (EPT/RI)
25th Nov 20223:05 pmRNSForm 8.3 - APPRECIATE GROUP PLC
25th Nov 20229:01 amRNSForm 8.3 - Appreciate Group PLC
24th Nov 20223:14 pmRNSHolding(s) in Company
24th Nov 20223:00 pmRNSForm 8.3 - APPRECIATE GROUP PLC
24th Nov 202211:12 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Appreciate Group Plc.
23rd Nov 20223:15 pmRNSForm 8.3 - APPRECIATE GROUP PLC
23rd Nov 20221:44 pmRNSHolding(s) in Company
23rd Nov 202210:36 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Appreciate Group Plc
22nd Nov 20228:54 amRNSForm 8.5 (EPT/RI)
22nd Nov 20227:00 amRNSHalf Year Results
21st Nov 20225:16 pmRNSForm 8 - Appreciate Group Plc
21st Nov 202211:59 amRNSForm 8 - Appreciate Group plc
21st Nov 202211:43 amRNSForm 8.3 - Appreciate Group plc
17th Nov 20223:03 pmRNSForm 8.3 - APPRECIATE GROUP PLC
17th Nov 20222:03 pmRNSHolding(s) in Company
17th Nov 20228:37 amRNSForm 8.5 (EPT/RI)
16th Nov 20222:46 pmRNSHolding(s) in Company
16th Nov 20222:34 pmRNSHolding(s) in Company
16th Nov 202210:18 amRNSForm 8.3 - Appreciate Group PLC
16th Nov 20228:27 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
15th Nov 20222:17 pmRNSForm 8.3 - Appreciate Group PLC
15th Nov 20229:41 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
14th Nov 20223:20 pmRNSForm 8.3 - APPRECIATE GROUP PLC
11th Nov 202210:08 amRNSForm 8.3 - Appreciate Group
11th Nov 20228:39 amRNSForm 8.5 (EPT/RI)
11th Nov 20228:21 amRNSForm 8.3 - Appreciate Group PLC
11th Nov 20227:47 amRNSHolding(s) in Company
11th Nov 20227:00 amRNSForm 8.3 - Appreciate Group PLC
10th Nov 20222:42 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - APPRECIATE GROUP PLC - Ordinary Shares
10th Nov 20228:59 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
10th Nov 20228:47 amRNSForm 8.3 - Appreciate Group PLC
10th Nov 20228:34 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.